Sort by
Refine Your Search
-
Listed
-
Employer
- Northeastern University
- Harvard University
- Cornell University
- Florida International University
- Indiana University
- The University of Chicago
- University of California, Los Angeles
- University of Texas at Austin
- University of Washington
- Yale University
- University of Arkansas
- University of Cincinnati
- University of Colorado
- University of Minnesota
- University of North Carolina at Chapel Hill
- Johns Hopkins University
- University of California
- University of South Carolina
- University of Utah
- Center for Astrophysics | Harvard & Smithsonian
- Cold Spring Harbor Laboratory
- Missouri University of Science and Technology
- Pennsylvania State University
- Princeton University
- University of Kansas Medical Center
- University of Notre Dame
- University of Pennsylvania
- Washington University in St. Louis
- Zintellect
- BU Pulmonary
- Carnegie Mellon University
- City of Hope
- Dartmouth College
- East Asian Observatory
- George Mason University
- H. Lee Moffitt Cancer Center & Research Institute
- Hanyang University
- Harvey Mudd College
- New York University
- PRINCETON UNIVERSITY
- Rutgers University
- SUNY University at Buffalo
- Sejong University
- Simons Foundation/Flatiron Institute
- The Infinity Fellowship
- The Ohio State University
- University of Alabama, Tuscaloosa
- University of Chicago (UC)
- University of Florida
- University of Maryland School of Medicine, Baltimore
- University of Maryland, Baltimore
- University of Michigan - Ann Arbor
- University of North Carolina
- 43 more »
- « less
-
Field
-
, and scholarly activities. In partnership with Northeastern University, Vertex Pharmaceuticals is offering a two-year North American Commercial—US Market Access Strategy fellowship, based in Boston, MA
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year US Market Access fellowship, based in Cambridge, MA . About Alnylam Alnylam
-
, and scholarly activities. In partnership with Northeastern University, Vertex Pharmaceuticals is offering a two-year North American Commercial – US Market Access Trade and Distribution Strategy
-
access to a range of educational, cultural, and recreational activities. With its historical significance and landmarks, lively cultural offerings, and wide variety of atmospheres, Philadelphia is the
-
access to unique multimodal datasets derived from prospective clinical trials, large-scale electronic health record (EHR) resources, medical imaging, and multi-omic profiling platforms, including genomic
-
exposure to our high-energy, fast-paced, and supportive culture. The HEOR and Evidence Strategy team sits within the Market Access and Patient Services team in the Commercial Organization. At Intellia, a
-
until a suitable candidate is found. The earliest anticipated start date is October 19, 2026. Dr. Drew Capone’s research group (https://caponelab.publichealth.indiana.edu ) has broad interests in
-
, friendly environment with access to resources and training every step of the way. The Medical Affairs Fellowship The Medical Affairs Fellowship at Chiesi Global Rare Diseases provides a comprehensive
-
faculty member in the College of Arts & Sciences to serve as their faculty host. For more information about eligibility, terms of the fellowship, and how to apply, please visit: https://as.cornell.edu
-
the candidate is applying (e.g., Smith, John – Alnylam, GSK) Please ask your letter writers to complete and submit the Letter of Recommendation Form along with their recommendation. Click here to access